For & Against

Claude View

What's Next

HCL Technologies reports Q4 FY2026 and full-year results on April 21, 2026 — tomorrow. The board will also consider an interim dividend for FY2027. This is the most consequential earnings print in over a year for the stock.

The market is watching one thing above all else: can HCL demonstrate that margin compression has bottomed? Q3 FY26 delivered 18.6% EBIT margin (including 81 bps of restructuring costs), meaning underlying margins were close to 19.4%. If Q4 confirms this trajectory and FY27 guidance points to 19-20% sustainable EBIT margins, the stock has room to re-rate. If margins slip again, the 470 bps compression from FY2021 peaks will look structural rather than cyclical.

For / Against / My View

For

Margin recovery is real, not just narrative. Q3 FY26 underlying EBIT margin of ~19.4% (after stripping 81 bps restructuring) marks a genuine inflection from the 16.3% trough in Q1 FY26. That is 310 bps of improvement in two quarters — faster than any margin recovery in HCL's recent history. The restructuring costs roll off after Q4, creating a natural tailwind into FY27. Quant's numbers confirm ROCE has improved from 25% to 32% over three years even as reported margins compressed, signaling the underlying business is getting more efficient.

Cash generation is elite and shareholders get paid. FCF conversion has averaged 127% of net income over five years — meaning HCL generates more cash than reported earnings. At ₹212B FCF in FY2025 against a ₹3.87 lakh crore market cap, the FCF yield is 5.5%, with a 3.7% dividend yield backed by a 94% payout ratio. For a business with 0.09x debt-to-equity and zero promoter pledge, this is one of the cleanest cash return stories in Indian large-caps.

Engineering services and software provide structural differentiation. Warren highlights that HCL's 16% Engineering & R&D segment and 10% HCLSoftware business command higher margins and stickier client relationships than commodity IT outsourcing. ERS grew 5.5% in FY25 despite macro headwinds. If management can shift the mix toward 20-25% ERS (from 16%), the stock deserves engineering multiples (25-30x P/E) rather than services multiples (18-22x). No other top-5 Indian IT firm has this optionality.

Governance is a strength, not a concern. Sherlock scores governance at 8.5/10 — zero promoter pledge on a 60.8% holding, 70% board independence, 50% women directors, and external ethics certifications (Ethisphere, ISO 37001). The promoter-professional management separation under CEO Vijayakumar has delivered consistent execution. This is a management team that has never missed the low end of guidance in three years.

Against

Margins remain 400-500 bps below TCS and Infosys, and the gap may be structural. HCL's FY2025 operating margin of 21.8% compares to TCS at 26.4% and Infosys at 24.1%. Quant's peer comparison shows TCS achieves 63% ROCE versus HCL's 32% — nearly double. If HCL's margin gap reflects structural factors (lower offshore mix, higher subcontracting, weaker pyramid optimization) rather than temporary investments, the current 22.6x P/E premium over TCS (17.8x) and Infosys (18.4x) is unjustified. Watch whether Project Ascend delivers measurable margin improvement in FY27 or remains a management talking point.

Revenue growth is decelerating into a potential demand shock. Constant currency growth slowed to 4.8% in FY25 services, below the 6-8% peer average. FY26 guidance was cut from 3-5% to 2-5% amid tariff uncertainty. With 58% of revenue from the US and 93% from exports, any freeze in enterprise IT budgets — plausible given tariff escalation — would hit HCL's top line within two quarters. Historian notes the FY26 guidance at 3.5% growth is the most conservative in three years. The stock price has already fallen 13-22% over the past year, but further downside exists if FY27 guidance disappoints.

The AI narrative lacks hard evidence of economic value creation. Management claims $100M+ quarterly Advanced AI revenue — but this metric was introduced in FY26 with no historical comparables and excludes classical AI/ML. Historian flagged that management quietly dropped "Digital Revenue %" as a metric after FY24, folding it into broader AI narratives. Warren asks the right question: is GenAI additive revenue (clients spend more) or substitutive (AI replaces billable headcount)? If AI productivity reduces revenue-per-employee by 20-30% over 3-5 years as Warren warns, HCL's people-leverage model faces an existential repricing.

CEO compensation doubled without corresponding performance. Sherlock documents an 80% increase in CEO pay to $18.6M in FY2025 — while margins compressed and revenue growth slowed. The CEO holds only 0.25% direct equity despite $18.6M total compensation. When pay accelerates faster than results, it signals misalignment that Sherlock correctly flags as a moderate concern.

My View

This is a close call with a slight lean toward patience. The Against side carries more weight right now because margin recovery, while encouraging in Q3, remains unproven over a full cycle — and tomorrow's Q4 result is the single most important data point. HCL is a genuinely high-quality business with elite cash conversion and a clean governance structure, but quality alone does not justify a P/E premium over TCS and Infosys when returns on capital trail both by a wide margin. I would wait for Q4 FY26 results and FY27 guidance before building a position: if management delivers exit EBIT margins above 19% and guides FY27 growth above 5% constant currency, the stock at ₹1,480 offers a credible re-rating path toward 25x earnings. The condition that would flip this view bullish is two consecutive quarters of margin expansion alongside accelerating AI revenue — that would confirm the restructuring is working and the engineering moat is translating into pricing power.